M. England

发表

Humoral Immune Responses in a Human Case of Glanders

D. DeShazer, D. Waag, M. England, 2012, Clinical and Vaccine Immunology.

Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies

D. DeShazer, D. Waag, N. Parthasarathy, 2006, Diagnostic Microbiology and Infectious Disease.

Vaccines against Coxiellosis and Q Fever Development of a Chloroform:Methanol Residue Subunit of Phase I Coxiella burnetii for the Immunization of Animals

J. Williams, D. Waag, M. Peacock, 1992, Annals of the New York Academy of Sciences.

Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.

D. Waag, M. Pitt, W. Byrne, 2002, Vaccine.

Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.

D. Waag, M. Pitt, M. England, 1997, Vaccine.

In Vitro Antibiotic Susceptibilities ofBurkholderia mallei (Causative Agent of Glanders) Determined by Broth Microdilution and E-Test

D. Waag, W. Byrne, H. Heine, 2001, Antimicrobial Agents and Chemotherapy.

Application of Polysaccharide Microarray Technology for the Serodiagnosis of Burkholderia pseudomallei Infection (Melioidosis) in Humans

D. DeShazer, S. Peacock, D. Waag, 2008 .

Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies.

D. DeShazer, D. Waag, N. Parthasarathy, 2008, Diagnostic microbiology and infectious disease.

Real-time PCR for the early detection and quantification of Coxiella burnetii as an alternative to the murine bioassay.

D. Norwood, D. Waag, D. Kulesh, 2009, Molecular and cellular probes.

Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis

J. Williams, D. Waag, G. Sandstrom, 1995, Clinical and Diagnostic Laboratory Immunology.

Low-Dose Priming before Vaccination with the Phase I Chloroform-Methanol Residue Vaccine against Q Fever Enhances Humoral and Cellular Immune Responses to Coxiella burnetii

D. Waag, M. England, C. Bolt, 2008, Clinical and Vaccine Immunology.

Immunogenicity of a new lot of Francisella tularensis live vaccine strain in human volunteers.

J. Williams, G. Sandström, D. Waag, 1996, FEMS immunology and medical microbiology.

Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis

J. Williams, D. Waag, G. Sandstrom, 1992, Journal of clinical microbiology.

Mouse models of aerosol-acquired tularemia caused by Francisella tularensis types A and B.

D. Waag, D. Fritz, L. Miller, 2014, Comparative medicine.

Detection of the host immune response to Burkholderia mallei heat-shock proteins GroEL and DnaK in a glanders patient and infected mice.

D. DeShazer, D. Waag, W. Ribot, 2007, Diagnostic microbiology and infectious disease.

Monoclonal Antibodies Passively Protect BALB/c Mice against Burkholderia mallei Aerosol Challenge

D. Waag, T. Chanh, P. Gibbs, 2006, Infection and Immunity.

Low-Dose Priming before Vaccination with the Phase I Chloroform-Methanol Residue Vaccine against Q Fever Enhances Humoral and Cellular Immune Responses to Coxiella burnetii

D. Waag, M. England, C. Bolt, 2008, Clinical and Vaccine Immunology.